Clinicopathological significance of MCTs was shown in metastatic samples of melanoma: MCT4 expression significantly increased in metastatic samples, and MCT1 and MCT4 were significantly associated with poor prognostic variables [82]. This evidence concerns the gene SLC16A1 and melanoma.